103 related articles for article (PubMed ID: 21863614)
21. A Review of the Impact of Pharmacogenetics and Metabolomics on the Efficacy of Metformin in Type 2 Diabetes.
Damanhouri ZA; Alkreathy HM; Alharbi FA; Abualhamail H; Ahmad MS
Int J Med Sci; 2023; 20(1):142-150. PubMed ID: 36619226
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenetics of oral antidiabetic drugs.
Becker ML; Pearson ER; Tkáč I
Int J Endocrinol; 2013; 2013():686315. PubMed ID: 24324494
[TBL] [Abstract][Full Text] [Related]
23. [Therapy of type 2 diabetes. Critical evaluation of oral antidiabetic drugs].
Landgraf R
MMW Fortschr Med; 2000 May; 142(21):33-7. PubMed ID: 10872292
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugs.
Efendic S; Alvarsson M; Brismar K; Wagner H
Acta Physiol (Oxf); 2008 Jan; 192(1):117-25. PubMed ID: 18171434
[TBL] [Abstract][Full Text] [Related]
25. Sitagliptin: a novel drug for the treatment of type 2 diabetes.
Choy M; Lam S
Cardiol Rev; 2007; 15(5):264-71. PubMed ID: 17700385
[TBL] [Abstract][Full Text] [Related]
26. Effective switch from premixed to basal-prandial insulin to achieve glycemic goals in type 2 diabetes.
Lavernia F
Postgrad Med; 2010 May; 122(3):28-32. PubMed ID: 20463411
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs.
Panicker GK; Karnad DR; Salvi V; Kothari S
J Assoc Physicians India; 2012 Jan; 60():56-61. PubMed ID: 22715547
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenetic Evaluation of Metformin and Sulphonylurea Response in Mexican Mestizos with Type 2 Diabetes.
Marta M; Sánchez-Pozos K; Jaimes-Santoyo J; Monroy-Escutia J; Rivera-Santiago C; de Los Ángeles Granados-Silvestre M; Ortiz-López MG
Curr Drug Metab; 2020; 21(4):291-300. PubMed ID: 32407269
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenetics and personalized treatment of type 2 diabetes.
Semiz S; Dujic T; Causevic A
Biochem Med (Zagreb); 2013; 23(2):154-71. PubMed ID: 23894862
[TBL] [Abstract][Full Text] [Related]
30. Pioglitazone and rosiglitazone for diabetes.
Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
[TBL] [Abstract][Full Text] [Related]
31. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenetics of oral antidiabetes drugs: evidence for diverse signals at the IRS1 locus.
Prudente S; Di Paola R; Pezzilli S; Garofolo M; Lamacchia O; Filardi T; Mannino GC; Mercuri L; Alberico F; Scarale MG; Sesti G; Morano S; Penno G; Cignarelli M; Copetti M; Trischitta V
Pharmacogenomics J; 2018 May; 18(3):431-435. PubMed ID: 28696414
[TBL] [Abstract][Full Text] [Related]
33. Computational Analysis of Single Nucleotide Polymorphisms Associated with Altered Drug Responsiveness in Type 2 Diabetes.
Costa V; Federico A; Pollastro C; Ziviello C; Cataldi S; Formisano P; Ciccodicola A
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347941
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenetics of glucose-lowering drug treatment: a systematic review.
Bozkurt O; de Boer A; Grobbee DE; Heerdink ER; Burger H; Klungel OH
Mol Diagn Ther; 2007; 11(5):291-302. PubMed ID: 17963417
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
Florez JC
Diabetologia; 2017 May; 60(5):800-807. PubMed ID: 28283684
[TBL] [Abstract][Full Text] [Related]
36. Precision medicine: The future in diabetes care?
Scheen AJ
Diabetes Res Clin Pract; 2016 Jul; 117():12-21. PubMed ID: 27329017
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenetics in diabetes.
Pearson ER
Curr Diab Rep; 2009 Apr; 9(2):172-81. PubMed ID: 19323963
[TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetic impact of SLC22A1 gene variant rs628031 (G/A) in newly diagnosed Indian type 2 diabetes patients undergoing metformin monotherapy.
Singh S; Shukla AK; Usman K; Banerjee M
Pharmacogenet Genomics; 2023 Apr; 33(3):51-58. PubMed ID: 36853844
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetics and future strategies in treating hyperglycaemia in diabetes.
Pearson ER
Front Biosci (Landmark Ed); 2009 Jan; 14(11):4348-62. PubMed ID: 19273354
[TBL] [Abstract][Full Text] [Related]
40. Effect of Metformin on Glycemic Control Regarding Carriers of the
Zepeda-Carrillo EA; Ramos-Lopez O; Martínez-López E; Barrón-Cabrera E; Bernal-Pérez JA; Velasco-González LE; Rangel-Rios E; Bustamante Martínez JF; Torres-Valadez R
Diabetes Metab Syndr Obes; 2022; 15():1771-1784. PubMed ID: 35711690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
